相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。被撤回的出版物: Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis through the Down-regulation of Cell Survival Proteins and Up-regulation of Death Receptors (Retracted article. See vol. 291, pg. 16920, 2016)
Bokyung Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails
Y. Niu et al.
ONCOGENE (2010)
DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells
A. D. Sanlioglu et al.
CANCER GENE THERAPY (2007)
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
Larisa L. Belyanskaya et al.
MOLECULAR CANCER (2007)
Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression:: DR5 and caspase 8 are key players
Vincent Hesry et al.
PROSTATE (2006)
APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy
O Bucur et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
TNF-α-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate
D Vindrieux et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies
M MacFarlane et al.
CANCER RESEARCH (2005)
Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis
L Clancy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Divergent biological effects of estradiol and diethylstilbestrol in the prostate cancer cell line MOP
JJ Kalach et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice
J Shi et al.
CANCER RESEARCH (2005)
XIAP as a target for therapeutic apoptosis in prostate cancer
GR Devi
DRUG NEWS & PERSPECTIVES (2004)
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis
M Chawla-Sarkar et al.
CELL DEATH AND DIFFERENTIATION (2004)
Death receptor-induced cell death in prostate cancer
NV Guseva et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer
XP Zhang et al.
CANCER RESEARCH (2004)
Caspase-3 and-6 expression and activation are targeted by hormone action in the rat ventral prostate during the apoptotic cell death process
A Omezzine et al.
BIOLOGY OF REPRODUCTION (2003)
Gene profiling and promoter reporter assays: Novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action
D Bigler et al.
ONCOGENE (2003)
Identification of tumor necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL) and its receptors in adult rat ventral prostate
D Vindrieux et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells
A Munshi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP
OW Rokhlin et al.
PROSTATE (2002)
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
A Ashkenazi
NATURE REVIEWS CANCER (2002)
Expression of tumor necrosis factor-α-related apoptosis-inducing ligand and its receptors in rat testis during development
R Grataroli et al.
BIOLOGY OF REPRODUCTION (2002)
The endocrinology of prostate cancer
ME Taplin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
分享论文
